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ABSTRACT  
Objective: Intake of vitamin E, C and A have been reported to reduce lung cancer risk because of their roles as regulators of cell differentiation 
(vitamin A), antioxidants (vitamins C and E), and modulators of DNA synthesis, methylation and repair. Some case-control studies have found 
inverse associations between intakes of these vitamins and lung cancer risk. However, most of the prospective studies evaluating these nutrients 
have not found clear inverse associations. Because many of these prospective studies have included less than 100 lung cancer cases, they lacked 
statistical power to detect modest inverse associations. Therefore, in order to address the national issue the present study attempted a little beat to 
explore the association between some antioxidant vitamins with lung cancer.  
Methods: In this study we investigated cases (lung cancer) and control group (Smoker); serum Vitamin A, Vitamin C and Vitamin E level estimation 
were focused. Detailed information on these facts was collected by questionnaire and blood sample analysis, which were then complied and 
analyzed with a statistical software package.  
Results: In this study we found that Serum vitamin C levels were significantly higher in case (0.8 ± 0.2 µg /dl) than in control (0.30±0.1µg/dl). But 
Serum vitamin A and serum vitamin E level showed less difference between cases (75.89±24.1µg/dl) and (657.25±322.7µg/dl) and controls 
(74.87±26.6µg/dl) and (641.55±413.5µg/dl) respectively.  
Conclusion: It can be suggested that vitamin E, C, and A has no effect on lung cancer patients. 
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INTRODUCTION 
Lung cancer is an uncontrolled growth of abnormal cells that start 
off in one or both lungs; usually in the cells that line the air passages. 
If left untreated, this growth can spread beyond the lung in a process 
called metastasis into nearby tissue and eventually, into other parts 
of the body. Most cancers that start in lung, known as primary lung 
cancers, are carcinomas that derive from epithelial cells. Lung 
cancer can be broadly classified into two main types based on the 
cancer's appearance under a microscope: non-small cell lung cancer 
and small cell lung cancer. Non-small cell lung cancer (NSCLC) 
accounts for 80% of lung cancers, while small cell lung cancer 
accounts for the remaining 20%. The incidence of lung carcinoma 
has increased intensely during the 20th
In Bangladesh it is also the most common cancer of males. A recent 
study conducted with 701 lung cancer patients for one year showed 
that 85% of them were male patient (608 male: 93 female- 6.53:1) 
[3]. It reveals the fatalities of lung cancer in Bangladesh. Main causes 
of the lung cancer are free radical or oxidant and genetic factors. 
Free radicals are highly reactive molecules that are produced in the 
body naturally as a byproduct of metabolism (oxidation), and by 
exposure to toxins in the environment such as tobacco smoke and 
ultraviolet light. Free radicals contain an unpaired electron. Simply 
put, they are in a constant search to bind with another electron to 
stabilize them -- a process that can cause damage to DNA and other 
parts of human cells. This damage may play a role in the 
development of cancer and other diseases, and accelerate the aging 
process. Actually free radical or oxidants oxidize DNA to change its 
sequence to form wrong sequence DNA. This DNA creates abnormal 
cell or malignant cell in lung. Thus result lungs becomes to cancer. 
Although tobacco smoking is claimed to be the most common cause 
of lung cancer (IARC, 2002) [4], respiratory diseases due to asbestos 
inhalation are also responsible to increase the risk of developing 
lung cancer [5]. Cigarette smoke contains over 60 known 
 century. Hundred year’s back 
it was not so severe disease to be reported but currently it is the 
commonest cause of death in developed as well as in developing 
countries [1]. On the basis of GLOBOCAN 2008 statistics lung cancer 
is the leading cancer in males, comprising 17% of the total new 
cancer cases and 23% of the total cancer deaths globally [2].  
carcinogens [6] or oxidizing agents including radioisotopes from the 
radon decay sequence, nitrosamine and benzopyrene. Additionally, 
nicotine appears to depress the immune response to malignant 
growths in exposed tissue [7]. 
If we suppress this oxidizing agent or carcinogen, must treat with 
antioxidant. Antioxidants are substances that may protect cells 
against the affects of free radical. Antioxidant substances include 
Beta-carotene, Lutein, Lycopene, Selenium, Vitamin A, 
Carcinogens are a class of substances 
that are directly responsible for damaging DNA and promoting or 
aiding cancer. Tobacco, asbestos, arsenic, radiation such as gamma, 
x-rays and the sun, and compounds in car exhaust fumes are all 
examples of carcinogens. When our bodies are exposed to 
carcinogens, free radicals are produced that try to steal electrons 
from other molecules in the body. These free radicals damage cells 
and affect their ability to function and divide normally.  
Vitamin C, 
Vitamin E etc. Several studies have looked at the relationship 
between smoking and serum plasma level of various antioxidant 
nutrient statuses. Low plasma level of antioxidants has been 
reported in lung cancer patients [8] [9], have 12 times more risk of 
lung cancer having low level of vitamin E in serum than healthy 
person [10]. However, an investigation on the relation between lung 
cancer incidence fruits and vegetable consumption appeared to 
confer no protection from lung cancer [11]. While a study appeared 
to show that high dose of beta carotene supplementation increased 
the risk of lung cancer among current smokers [12]. Another study 
showed that lung cancer is not dependent on beta carotene and 
retinol supplementation rather more case and gender specific [13]. 
This study attempts to investigate whether any association of 
antioxidant vitamins A, C, and E with lung cancer or not.  
MATERIALS AND METHODS  
Population Study 
The study included 120 people comprising 60 lung cancer patients 
and 60 smokers as cohort controls during June to October 2013. 
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Randomly selected lung cancer patients were admitted in to Dhaka 
medical college hospital, Mitford hospital, Cancer institute and some 
clinics in Dhaka city. The smoker controls were preferably from the 
community. The age limit was between 40 to 60 years and patients 
had with the strong clinical features of lung cancer and was in 
medication and vitamin supplementation. 
Every cancer patient and smoker control was selected randomly on 
basis of the following inclusion criteria. 
(¡) Strong history of smoking 
(¡¡) Long term more consumption of cigarette smoking 
(¡¡¡) No history of other drugs which can cause the drugs addiction 
(¡v) Cancer patient have strong and long term smoking history 
Resident physician of the respective hospital, on the basis of history, 
clinical and laboratory findings advised the cancer patients to take 
treatment either taking admission or outdoor treatment into the 
hospital. After briefing the purpose of the study, written consent was 
taken from the patients or from their guardian and then included in 
the study. After having the consent, participant was asked to report 
on a prefixed date for interview and blood sampling. 
A questionnaire was developed to obtain the relevant information’s. 
It included: general information, socioeconomic information, 
anthropometric data, dietary history, smoking habit, clinical signs 
and symptoms, vitamins and drug taking information. 
After collection of the socio-demographic anthropometric and 
dietary data; 5.0ml of blood was drawn from the subject arm and 
aliquot of 2.0 ml of this blood sample was placed in a heparinized 
tube to collect the plasma sample for vitamin C estimation. The 
remaining 3.0 ml blood was centrifuge- test tube which was washed 
with acid and de-ionized water. Centrifuge tube was immediately 
wrapped in aluminum foil to protect vitamin A against degradation 
by light. The blood sample was allowed to stand at room 
temperature for approximately 2hrs. After centrifugation serum 
samples were separated frozen and stored at – 20 0
Estimation of serum vitamin A (retinol) and vitamin E (α-
tochopherol) 
C until further 
analysis. 
Serum vitamin A and vitamin E were measured simultaneously by a 
modification of the method of Bieri et al, using HPLC, equipped with 
reversed – phase column of Waters of Bondapak C 18 125 Ao
Trans-retinol (Sigma Chemical Company, Saint Louis, Missouri, USA) 
and dl-alpha- tocopherol (Sigma Chemical Company, Saint Louis, 
Missouri, USA) were used as the external standard for vitamins A 
and vitamins E respectively. Retinol acetate (Sigma, USA) and 
tocopherol acetate (Sigma, USA) were used as the internal standard 
for vitamins A and vitamins E respectively. Retinol standard (stock) 
Retinol (10.0 mg) was dissolved in 100 ml absolute alcohol and was 
stored at -20 
10µM 
(3.9 ×300mm) HPLC column. A guard column (5.0 cm x 0.5 cm) 
packed with octadecyl silica preceded the primary column. For 
extraction purpose absolute alcohol (BDH, UK.) and extra pure 
hexane (Merck, Germany) were used and the eluting solvent was 
extra pure methanol (Merck, Germany) water at ratio of 97.5: 2.5, 
where the injection volume during operation was 20 µl. 
0C. Retinol Acetate standard (stock) Retinol Acetate (10 
mg) was dissolved in absolute alcohol (100ml) and stored at -20 0C. 
Alpha- tocopherol (stock).Alpha- tocopherol (10mg) was dissolved in 
absolute alcohol to make a final volume of 100ml and stored at -20 0C. 
Alpha- tocopherol Acetate (stock) Alpha- tocopherol acetate (10mg) was 
dissolved in 100ml of absolute alcohol and stored at -20 0
To measure vitamin A and vitamin E simultaneously, retinol stock 
standard was diluted to following concentration; 25, 50, 75, and 100 
µg /dl and alpha- tocopherol was diluted to the following 
concentrations; 250, 500, 750 and 1000µg / dl. A constant amount of 
retinol acetate 50µg /dl and alpha- tocopherol acetate 5.0mg/dl 
were also added as internal standard to each of the concentration of 
retinol and alpha- tocopherol solution. For internal standard, Stock 
retinol acetate, 0.5ml and 50.0ml of tocopherol acetated were 
diluted to 100ml with absolute alcohol to obtain a concentration of 
50µg /dl retinol acetate and 5.0 mg/dl for tocopherol acetate. To 
determine the retention time of retinol, alpha- tocopherol, retinol 
acetate and tocopherol acetate, each was applied into HPLC 
instrument separately at a concentration of 100 µg /dl. The 
retention times were calculated from the chromatograms.  
C.  
For analysis of serum retinol and α-tocopherol, serum sample 
(100µl) was mixed with 100µl of the internal standard solution to a 
concentration of 50 and 100 µg/dl for retinol acetate and 5.0 mg/dl 
for alpha-tocopherol acetate. The contents were mixed with a vortex 
mixer for 15 sec. For extraction of lipids, 500 µl of hexane was added 
and mixed for 45 sec in a vortex mixer. The tubes were centrifuged 
at 10000 rpm.for10 min and the top of the hexane layer was 
separated. The hexane was evaporated under a stream of nitrogen 
gas. The extracted vitamins A and E then re-dissolved in 100µl 
absolute alcohol. The solution was then injected in to the HPLC 
instruments. A solvents flow of 1.0 ml/ min was used. Elution was 
monitored at 291 nm. The pick height ratios for retinol and alpha-
tocopherol were calculated and the amounts were read from the 
standard curve.  
Day to day variation for vitamin A and E assay were determined 
using a polled serum sample for a period of 10 days. The inter assay 
variation for vitamin A 2.3% and for vitamin E was 3.3%. 
Estimation of plasma ascorbic acid 
Plasma ascorbic acid was measured by dinitriphenyl hydralazine 
method. In this method, an aliquot of 0.2 ml serum was taken in a 
5.0ml test tube, 0.8ml 5.0% TCA was added and mixed immediately 
using a vortex mixer. The mixer was then centrifuged at 3000 rpm 
for 10 min. An aliquot of 0.6 ml supernatant was taken and 0.25 ml 
of DTC solution was added. The tube was covered with paraflim and 
then incubated at 60 0C for 1 hr in a water bath. Immediately after 
the incubation, the test tube was chilled in an ice cool water bath. 1 
ml 65% sulphuric acid was then added drop wise and mixed well 
solution then. Incubated at room temperature 25 0
Statistically Analysis 
C for 30 min. 
working standard solution, 0.2ml was taken and treated as serum 
sample. The blank was prepared by taking 0.6 ml 5.0% TCA and 0.25 
ml DTC solution and treated in the same procedure as serum.  
SPSS software package (version 20.0, IBM SPSS Inc. Chicago, USA) 
was used to analyze the data. Descriptive statistics were calculated 
for all variables. Values were expressed as mean ± SD. Comparison 
of groups in Lung cancer patients and Control smoker were 
performed by independent sample p-test. 
RESULTS AND DISCUSSIONS 
Vitamin C and vitamin E are powerful antioxidants found in the lung 
where they protect against oxidative damage [14]. There is growing 
body epidemiologic evidence suggesting that antioxidants such as 
Beta-carotene, Vitamin C and alpha-tocopherol may modify the 
incidence the respiratory tract cancer both in smokers and 
nonsmokers. Decrease concentration of Vitamin C in plasma and 
Vitamin E in epithelial lining fluid has been observed in smokers, 
suggesting that cigarette smoking may induce the oxidative stress on 
respiratory system and that dietary antioxidants may diminish the 
deleterious effects of cigarette smoking. However, the therapeutic 
use of alpha-tocopherol and beta-carotene to ameliorate the adverse 
effects to cigarette smoke has been questioned recently. There are 
several studies that have analyzed the association between dietary 
intake of these antioxidant vitamins and respiratory function [15]. A 
large number of studies have found positive associations between 
pulmonary function and intake of vitamin C or foods high in vitamin C 
content (i.e., fresh fruit and vegetable) [16–20]. Fewer studies have 
analyzed the relation of dietary vitamin E intake with pulmonary 
function and have reported contradictory findings [17] [18].  
In our Study, we found vitamin E in serum is 657.25±322.7 µg/dl 
and 641.55±413.5 µg/dl for lung cancer and control smoker 
respectively (Table-1). Slightly difference is found from these values. 
From these values serum Vitamin E level of Lung cancer patients is 
slightly higher than control smoker. This results in not significant. 
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Vitamin C in serum is 0.85±0.2 µg/dl and 0.30±0.1 µg/dl of lung 
cancer and control smoker respectively in our findings (Table-1). 
Vitamin C level in lung cancer patients is significantly higher than 
the control smoker. Vitamin A in serum level is 75.89±24.1 µg/dl 
and 74.87±26.6 µg/dl of lung cancer and control smoker 
respectively (Table-1). This difference is not significant. In our 
finding serum Vitamin E, C, A level is higher in lung cancer patients 
than control smokers. 
Table 1: Serum vitamin E, C and A level of lung cancer patients 
and control smokers 
Vitamin Lung cancer Control smoker P value 
Vitamin E 657.25±322.7 641.55±413.5 0.82 
Vitamin C 0.85±0.2 0.30±0.1 0.00 
Vitamin A 75.89±24.1 74.87±26.6 0.94 
Level of significance: p<0.05 , All values unit= µg/dl, Data's are 
expressed as mean ± SD. 
 
In true sense Vitamin E, C, A level should be lower in Lung cancer 
patients than control smokers. Because Lung cancer patients need 
more anti-oxidant than control smokers for diminish their 
carcinogen or free radical that produce cancer cell. But not occur 
that. It may be no effect of Vitamin E, C and A on lung cancer patients 
and control smokers. 
The finding of this study was found consistent as reported by others. 
Tawee Tanvetyanon reported that high-dose of Beta-Carotene 
supplementation appears to increase the risk of lung cancer among 
current smokers [21]. A study found no reduction in the incidence of 
lung cancer among male smokers after five to eight years of dietary 
supplementation with alpha-tocopherol or beta carotene. In fact, this 
trial raises the possibility that these supplements may actually have 
harmful as well as beneficial effects [22]. Slatore CG reported that 
Supplemental multivitamins, vitamin C and vitamin E were not 
associated with a decreased risk of lung cancer. Supplemental 
vitamin E was associated with a small increased risk [23].  
CONCLUSION 
Based on the present experimental results, it can be suggested that 
vitamin E, C, and A has no effect on lung cancer patients. Higher level 
of Vitamin E, C and A in lung cancer patient may indicates high 
endogenous anti-oxidant secretes from the body due to inhibition of 
oxidation of cell.  
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